Specifically, it has been reported that when PARP1 is aberrantly activated in cancer cells, it blocks phosphorylation of STAT1 and STAT3 via the poly(ADP-ribosyl)ation, ultimately reducing their transcriptional activity [28,31]. The gene discussed is STAT1; the disease is cancer.